Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine /atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)HOBBS, F. D. Richard; GENSINI, Gianfranco; METCALFE, Michael et al.International journal of cardiology. 2006, Vol 110, Num 2, pp 242-250, issn 0167-5273, 9 p.Article